Incorporating Model Uncertainty in Detecting Rare Variants: The Bayesian Risk Index

Por Quintana, Melanie A., Berstein, Jonine L., Thomas, Duncan C., Conti, David V.
Publicado em 2011

Incorporating Prior Biologic Information for High Dimensional Rare Variant Association Studies

Por Quintana, Melanie A., Schumacher, Fredrick R., Casey, Graham, Bernstein, Jonine L., Li, Li, Conti, David V.
Publicado em 2013

Building Efficient Comparative Effectiveness Trials through Adaptive Designs, Utility Functions, and Accrual Rate Optimization: Finding the Sweet Spot

Por Gajewski, Byron J., Berry, Scott M., Quintana, Melanie, Pasnoor, Mamatha, Dimachkie, Mazen, Herbelin, Laura, Barohn, Richard
Publicado no Stat Med (2015)

A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer’s disease

Por Wang, Guoqiao, Berry, Scott, Xiong, Chengjie, Hassenstab, Jason, Quintana, Melanie, McDade, Eric M., Delmar, Paul, Vestrucci, Matteo, Sethuraman, Gopalan, Bateman, Randall J.
Publicado no Stat Med (2018)

A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization

Por Brown, Alexandra R., Gajewski, Byron J., Aaronson, Lauren S., Mudaranthakam, Dinesh Pal, Hunt, Suzanne L., Berry, Scott M., Quintana, Melanie, Pasnoor, Mamatha, Dimachkie, Mazen M., Jawdat, Omar, Herbelin, Laura, Barohn, Richard J.
Publicado no Trials (2016)

The DIAN-TU Next Generation Alzheimer’s prevention trial: adaptive design and disease progression model

Por Bateman, Randall J., Benzinger, Tammie L., Berry, Scott, Clifford, David B., Duggan, Cynthia, Fagan, Anne M., Fanning, Kathleen, Farlow, Martin R., Hassenstab, Jason, McDade, Eric M., Mills, Susan, Paumier, Katrina, Quintana, Melanie, Salloway, Stephen P., Santacruz, Anna, Schneider, Lon S., Wang, Guoqiao, Xiong, Chengjie
Publicado no Alzheimers Dement (2016)